Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David R Spigel, MD
Sarah Cannon, The Cancer Institute of HCA Healthcare
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
49 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Polyclinique Bordeaux Nord
Bordeaux, Cedex, France
- Hôpital Charles Nicolle
Rouen, Cedex, France
- Chu D'Angers Service Pneumologie
Angers, France
- Centre Hospitalier de la Côte Basque
Bayonne, France
- Chru Besançon- Hôpital J. Minjoz
Besançon, France
- Hôpital Aphp Ambroise Paré
Boulogne, France
- Hia Percy
Clamart, France
- Centre Hospitalier Intercommunal de Créteil
Créteil, France
- Centre Hospitalier Départemental Vendée
La Roche-sur-Yon, France
- Hôpital Privé Jean Mermoz
Lyon, France
- Hôpital Europeen
Marseille, France
- Hôpital Nord
Marseille, France
- Groupe Hospitalier Région de Mulhouse Sud -Alsace
Mulhouse, France
- Centre Hospitalier Universitaire de Nîmes
Nîmes, France
- Hôpital Bichat
Paris, France
- Hôpital Cochin
Paris, France
- Hôpital Paris Saint Joseph
Paris, France
- Hôpital Tenon
Paris, France
- Hôpital Haut-Lévèque (bordeaux - Chu)
Pessac, France
- Chu de Poitiers
Poitiers, France
- Hôpital Larrey
Toulouse, France
- Chru de Tours
Tours, France
- Gustave Roussy
Villejuif, France
- Köln-Merheim
Cologne, Germany
- München-Gauting
Gauting, Germany
- Niels-Stensen-Kliniken
Georgsmarienhütte, Germany
- Lung Clinic Grosshansdorf-Department of Thoracic Oncology
Großhansdorf, Germany
- Medizinische Hochschule Hannover
Hanover, Germany
- University Medical Center Schleswig-Holstein
Lübeck, Germany
- University Hospital of Munich
München, Germany
- Pius-Hospital Oldenburg Medizinischer Campus Universität Oldenburg
Oldenburg, Germany
- Leonard Cancer Institute
Mission Viejo, California, United States
- Uc Davis Comprehensive Cancer Center
Sacramento, California, United States
- Providence Medical Foundation Santa Rosa
Santa Rosa, California, United States
- Sarah Cannon- Fcs South
Fort Meyers, Florida, United States
- Sarah Cannon- Fcs North
Petersburg, Florida, United States
- Sarah Cannon- Fcs Panhandle
Tallahassee, Florida, United States
- Sarah Cannon- Fcs East
West Palm Beach, Florida, United States
- Baptist Health Lexington
Lexington, Kentucky, United States
- Baptist Health Louisville
Louisville, Kentucky, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Sept 2020
- Primary completion
- 15 May 2027
- Completion
- 15 May 2027
- Last update posted
- 13 Apr 2025
- Registered enrollment
- 420
- Registry id
- NCT01817192
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.